Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,580 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study.
Namikawa K, Kiyohara Y, Takenouchi T, Uhara H, Uchi H, Yoshikawa S, Takatsuka S, Koga H, Wada N, Minami H, Hatsumichi M, Asada S, Namba Y, Yamazaki N. Namikawa K, et al. Among authors: wada n. Eur J Cancer. 2018 Dec;105:114-126. doi: 10.1016/j.ejca.2018.09.025. Epub 2018 Nov 15. Eur J Cancer. 2018. PMID: 30447539 Free article. Clinical Trial.
Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy-naive advanced melanoma.
Namikawa K, Kiyohara Y, Takenouchi T, Uhara H, Uchi H, Yoshikawa S, Takatsuka S, Koga H, Wada N, Minami H, Hatsumichi M, Namba Y, Yamazaki N. Namikawa K, et al. Among authors: wada n. J Dermatol. 2020 Nov;47(11):1257-1266. doi: 10.1111/1346-8138.15514. Epub 2020 Aug 18. J Dermatol. 2020. PMID: 32812243 Free PMC article. Clinical Trial.
Melanoma and Immune Checkpoint Inhibitors.
Furue M, Ito T, Wada N, Wada M, Kadono T, Uchi H. Furue M, et al. Among authors: wada m, wada n. Curr Oncol Rep. 2018 Mar 23;20(3):29. doi: 10.1007/s11912-018-0676-z. Curr Oncol Rep. 2018. PMID: 29569208 Review.
Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma.
Yano S, Ashida K, Nagata H, Ohe K, Wada N, Takeichi Y, Hanada Y, Ibayashi Y, Wang L, Sakamoto S, Sakamoto R, Uchi H, Shiratsuchi M, Furue M, Nomura M, Ogawa Y. Yano S, et al. Among authors: wada n. BMC Endocr Disord. 2018 Jun 8;18(1):36. doi: 10.1186/s12902-018-0267-x. BMC Endocr Disord. 2018. PMID: 29884162 Free PMC article.
Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody.
Yamaguchi K, Mishima K, Ohmura H, Hanamura F, Ito M, Nakano M, Tsuchihashi K, Ota SI, Wada N, Uchi H, Ariyama H, Kusaba H, Niiro H, Akashi K, Baba E. Yamaguchi K, et al. Among authors: wada n. Cancer Sci. 2018 Oct;109(10):3032-3042. doi: 10.1111/cas.13758. Epub 2018 Aug 31. Cancer Sci. 2018. PMID: 30066977 Free PMC article. Clinical Trial.
1,580 results